Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 3.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.68% |
| Dec 31, 2025 | 60.61% |
| Sep 30, 2025 | 2,914.29% |
| Jun 30, 2025 | -623.08% |
| Mar 31, 2025 | 12.37% |
| Dec 31, 2024 | 112.07% |
| Sep 30, 2024 | 103.17% |
| Jun 30, 2024 | 388.89% |
| Mar 31, 2024 | 43.98% |
| Dec 31, 2023 | -649.32% |
| Sep 30, 2023 | -689.29% |
| Jun 30, 2023 | 98.19% |
| Mar 31, 2023 | 28.60% |
| Dec 31, 2022 | 23.16% |
| Sep 30, 2022 | 92.88% |
| Jun 30, 2022 | -1,029.55% |
| Mar 31, 2022 | -164.76% |
| Dec 31, 2021 | 87.11% |
| Sep 30, 2021 | 33.73% |
| Jun 30, 2021 | -109.40% |